Type of security: Stock
Sector: Health Care
The data is delayed by 15 minutes.
Description: Natus Medical Incorporated provides newborn care and neurology healthcare products worldwide. It offers healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company?s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn?s environment; and software systems for managing and tracking disorders and diseases for public health laboratories. It provides ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hearing screening devices. The company also offers diagnost
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||1.13||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||3.56%||Sales Growth - Q/Q||-4.91%||P/E||30.97|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||7.73%||ROE||9.57%||ROI|
|Current Ratio||3.06||Quick Ratio||2.48||Long Term Debt/Equity||Debt Ratio||0.2|
|Gross Margin||60.45%||Operating Margin||13.85%||Net Profit Margin||9.54%||Dividend Payout Ratio|
|Cash From Financing Activities||600 K||Cash From Investing Activities||-13.48 M||Cash From Operating Activities||13.81 M||Gross Profit||53.61 M|
|Net Profit||8.6 M||Operating Profit||13.35 M||Total Assets||443.74 M||Total Current Assets||218.24 M|
|Total Current Liabilities||71.39 M||Total Debt||Total Liabilities||85.17 M||Total Revenue||89.39 M|
|High 52 week||37.6||Low 52 week||23.83||Last close||24.04||Last change||0.88%|
|RSI||33.08||Average true range||0.6||Beta||0.8||Volume||1.09 M|
|Simple moving average 20 days||-4.94%||Simple moving average 50 days||-10.06%||Simple moving average 200 days||-25%|
|Performance Week||-5.28%||Performance Month||-9.11%||Performance Quart||-28.47%||Performance Half||-27.59%|
|Performance Year||-34.05%||Performance Year-to-date||-29.36%||Volatility daily||2%||Volatility weekly||4.46%|
|Volatility monthly||9.14%||Volatility yearly||31.67%||Relative Volume||414.44%||Average Volume||391.2 K|
|New High||New Low|
2019-10-31 06:00:00 | Else Nutrition Holdings Inc. Ushers in Next Generation of Clean Label Baby Nutrition
2019-10-25 22:34:11 | Edited Transcript of BABY earnings conference call or presentation 24-Oct-19 8:30pm GMT
2019-10-17 12:00:00 | Else Nutrition Holdings Inc. Provides Corporate Update
2019-09-18 11:10:00 | Else Nutrition Approved to Trade on the OTCQB Market
2019-08-21 12:27:26 | Else Nutrition Holdings Inc. Shareholder Update
2019-08-21 09:00:00 | Shareholders Update
2019-07-27 12:03:00 | Natus Medical Is All Grown Up
2019-07-25 22:35:41 | Edited Transcript of BABY earnings conference call or presentation 25-Jul-19 8:30pm GMT
2019-07-25 22:23:55 | Natus Medical Inc BABY Q2 2019 Earnings Call Transcript
2019-07-25 20:05:12 | Natus Medical BABY Q2 Earnings and Revenues Top Estimates
2019-07-25 16:22:50 | Natus Medical Announces Second Quarter 2019 Financial Results
2019-07-25 14:30:00 | Natus Medical, Inc. to Host Earnings Call
2019-07-25 12:30:00 | Natus Medical Announces NASDAQ Ticker Symbol Change to “NTUS”
2019-07-11 07:00:00 | Natus Medical to Hold 2019 Second Quarter Financial Results Conference Call on July 25th
2019-07-10 08:00:00 | Else Nutrition’s CEO Letter to Shareholders
2019-06-10 08:08:05 | See what the IHS Markit Score report has to say about Natus Medical Inc.
2019-06-08 08:11:36 | See what the IHS Markit Score report has to say about Natus Medical Inc.
2019-06-04 08:06:59 | See what the IHS Markit Score report has to say about Natus Medical Inc.
2019-05-21 09:07:04 | See what the IHS Markit Score report has to say about Natus Medical Inc.
2019-05-17 07:00:00 | Natus to Present at William Blair 39th Annual Growth Stock Conference
2019-05-15 18:04:22 | Argo’s Tack Runs Danger of Losing the Longer Race
2019-05-06 22:02:00 | INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Natus Medical, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-05-06 16:30:00 | Update to Natus Medical First Quarter 2019 Financial Results
2019-05-02 15:20:35 | Here’s What Hedge Funds Think About Natus Medical Inc BABY
2019-04-29 12:56:00 | Natus Medical Continues Its Restructuring
2019-04-25 22:13:36 | Edited Transcript of BABY earnings conference call or presentation 25-Apr-19 8:30pm GMT
2019-04-25 19:36:01 | Natus Medical Inc BABY Q1 2019 Earnings Call Transcript
2019-04-25 17:07:26 | Natus Medical: 1Q Earnings Snapshot
2019-04-25 16:05:00 | Natus Medical Announces First Quarter 2019 Financial Results
2019-04-25 14:30:00 | Natus Medical Incorporated to Host Earnings Call
2019-04-09 10:50:20 | See what the IHS Markit Score report has to say about Natus Medical Inc.
2019-04-08 16:30:00 | Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th
2019-04-08 10:13:02 | Natus Medical to Divest Medix for Focusing on Core Business
2019-04-02 16:30:00 | Natus Announces Sale of Medix Business
2019-03-28 08:06:01 | See what the IHS Markit Score report has to say about Natus Medical Inc.
2019-03-26 08:25:57 | See what the IHS Markit Score report has to say about Natus Medical Inc.
2019-03-25 14:48:00 | 1 Surprising Reason Alzheimer's Drugs Remain So Elusive